Equillium, Inc. (EQ) stock
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.29−0.03 (-2.27%)
Close on Nov 13, 2026Market cap $81.80MP/E –Yield –
Equillium price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Equillium's price to sales ratio was 0.4× on Apr 30, 2025, against 1.5× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Apr 30, 2025 | 0.4× | −0.2 |
| 2024 | Dec 31, 2024 | 0.6× | – |
See a number that looks wrong?